Gallinée, a brand specializing in microbiome-based skincare products, has increased the number of its points of sale in pharmacies in Europe by a factor of 10 since joining the Shiseido group, marking a decisive turning point in its development.
Since its acquisition by Shiseido in September 2022, Gallinée, which historically had a digital-first distribution model, has evolved to reach 1,250 pharmacy outlets today. «« Gallinée is a perfect illustration of our ambition to develop skincare brands with a strong scientific positioning in the pharmacy channel, where expertise, trust and recommendation are key. »explains Florian d'Hauteville, chief business officer of Shiseido EMEA. This expansion is part of a sustainable growth strategy, based on making dermocosmetic products more accessible.
A strategy focused on the microbiome
Gallinée has positioned itself as the first microbiome care brand to enter the pharmaceutical channel, a choice that allows it to take advantage of an environment where trust and expertise are paramount. Currently, the brand plans to open 300 new points of sale per national market, with a long-term objective of reaching 5,000 pharmacies in countries such as France, Italy and Spain.
This dynamic is accompanied by a number of innovations, including the use of emblematic products such as Face Vinegar, which has enjoyed significant success, with sales doubling in 2025 compared to 2024. The addition of new skincare products, such as Youthful Eye Cream, underlines Gallinée's capacity for continuous innovation.
Innovation and protection of the skin ecosystem
Gallinée is committed to supporting the skin's ecosystem without disturbing it, in line with the Shiseido group's scientific strategy, which focuses on the microbiome. The brand holds four patents, confirming its pioneering role in the sector. « Integration into the Shiseido Group has enabled us to accelerate our growth without ever abandoning our DNA. »says Marie Drago, founder and director of the chief creative officer of Gallinée. This philosophy of growth integrated with scientific research positions the brand as a major player in the skincare market.
